Navigation Links
Video: CLARITIN Partners with NASCAR Driver Carl Edwards to Educate Motorists on the Importance of Being Clear to Drive(SM)
Date:3/18/2009

- Safe Driving Pledge Unveiled as Part of Nationwide Awareness Campaign -

KENILWORTH, N.J., March 18 /PRNewswire-FirstCall/ -- This spring allergy season, Schering-Plough (NYSE: SGP), maker of the non-drowsy allergy medicine, CLARITIN, is continuing its partnership with allergy sufferer and NASCAR driver Carl Edwards to encourage safe driving practices.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/claritin/37512/

"Drowsy driving is dangerous so I'm participating in the CLARITIN Clear to Drive campaign because I want to make sure people know to check medicine labels for warnings about drowsiness before getting behind the wheel," said Edwards. "As someone who races cars for a living, I can't risk taking an allergy medicine that might make me drowsy. Now I use new CLARITIN(R) Liqui-Gels(R) because it relieves my worst allergy symptoms and it's the only non-drowsy option in an easy-to-swallow liquid-filled capsule."

For the second year in a row, Edwards is the voice of the CLARITIN Clear to Drive(SM) campaign, which aims to prevent drowsy driving and encourages people to stay alert while on the road. This year's campaign asks consumers to take an online pledge and commit to safe driving practices by visiting www.cleartodrive.com. For every pledge made, the makers of CLARITIN will donate $1 (up to $30,000) to the National Safety Council.

"As a leader in promoting safe driving practices, the National Safety Council supports the CLARITIN Clear to Drive(SM) campaign and its effort to prevent drowsy driving," said Janet Froetscher, president & chief executive of the National Safety Council. "Considering crashes are the number-one cause of accidental death in the U.S., it's important to pay close attention to our driving habits and take the necessary steps to stay alert on the road."

To learn more about drowsy driving and to take the Clear to Drive pledge, visit www.cleartodrive.com.

About CLARITIN(R)

All CLARITIN(R) brand products are available without a prescription, including: CLARITIN(R) Tablets, a once-daily, full prescription strength, non-drowsy formulation; CLARITIN(R) RediTabs(R) Tablets, a novel once-daily formulation in a quickly dissolving tablet for ages 6 and older; CLARITIN(R) Liqui-Gels(R), a once-daily formulation in an easy-to-swallow liquid-filled capsule; CLARITIN-D(R) 24-hour and 12-hour Extended Release Tablets, with the decongestant pseudoephedrine, now located behind the counter; CHILDREN'S CLARITIN(R) Syrup, a liquid formulation for children ages 2 and older in grape and fruit flavors; and CHILDREN'S CLARITIN(R) Grape Chewables, a chewable tablet for children ages 2 and older.

CLARITIN(R) is the No. 1 physician-recommended and pediatrician-recommended non-drowsy over-the-counter allergy brand. The CLARITIN(R) Rx-to-OTC switch in 2002 was the largest switch ever-and the first and only for a non-drowsy antihistamine. For more information on allergies and treatment, visit www.CLARITIN.com.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Record Number of Patients Seek Laser Treatments to Take Light-Years Off Their Faces
2. Video: New Report Card: Nations Mental Health Care System
3. Video: Injectable-Grade Filler, Now Without the Injections
4. Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women
5. Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent
6. Video: CVS/pharmacy and National Council on Aging Kick Off Medication Management Program for Seniors
7. Video: Facing the Facts - What You Need to Know About Facial Plastic Surgery
8. Video: Majority of Americans Over 45 Experience Joint Pain and Believe it will Affect Their Future Quality of Life
9. Video: The MDS Foundation Says Published Data Confirms VIDAZA(R) Significantly Extends Survival in Patients with the Malignant Condition MDS
10. Video: On 100th Anniversary, Mental Health America Declares Its Time for Mental Health
11. Video: Ear Infections Spark Online Conversations Among Concerned Parents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 2017 , ... Using the power of the internet, IdrisArkette.com has managed to ... period of just 24 months, thousands of individuals interested in a medical procedure managed ... “The internet is not getting quieter. In fact it’s becoming noisier by the day. ...
(Date:2/22/2017)... Delray Beach, FL (PRWEB) , ... February 22, 2017 , ... ... celebrity Wrestling Legend Kurt Angle, is now available on the App Store ... solutions and award-winning mobile apps for the addiction and recovery industry, partnered with Angle ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... related to spine practices, is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a ... of a small number of neurosurgeons in Michigan performing minimally invasive back surgery ...
(Date:2/22/2017)... PA (PRWEB) , ... February 22, 2017 , ... A ... some people seem to derive a heart-protective benefit from eating soy foods, while others ... , Japanese men who are able to produce equol—a substance made by some types ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... TAMPA, Fla. , Feb. 22, 2017  Corin ... Shoulder System, a device used to treat patients with ... form of shoulder arthritis. The condition, known as cuff ... arm and shoulder. The Humelock Reversed ... privately-held upper extremities technology company based near ...
(Date:2/22/2017)... 22, 2017 Research and Markets has ... Pipeline Review, 2016" report to their offering. ... Dermatological conditions ... and approximately one-third of the US population suffers from at ... majority of the dermatology market has remained saturated with established ...
(Date:2/22/2017)... , Feb 22, 2017 Research and ... Drugs Market by Drug Molecule (Biologic, Small Molecule Drugs), By ... Inhibitors, Interleukin Blockers) Outlook 2022" report to their offering. ... The ... growth during 2016-2022 This report provides a detailed ...
Breaking Medicine Technology: